SUBSTITUTED 1H-PYRAZOL-1,2,4-OXADIAZOLE DERIVATIVES AS SPHINGOSINE RECEPTOR MODULATORS
申请人:Allergan, Inc.
公开号:US20140235588A1
公开(公告)日:2014-08-21
The present invention relates to substituted 1H-pyrazol-1,2,4-oxadiazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
本发明涉及取代的1H-吡唑-1,2,4-噁二唑衍生物,其制备过程,含有它们的制药组合物以及它们作为调节鞘氨醇-1-磷酸受体的药物的用途。